Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment.

Kong, Cheng; Yu, Shaorong; Qian, Pudong; Song, Xue; Wen, Jing; Jiang, Ming; Zhu, Jun; Xu, Jianhua; Zhao, Lijun; Guo, Zhen; Wu, Jianfeng; He, Xia; Zhu, Xiangzhi

Kong, Cheng; Yu, Shaorong; Qian, Pudong; Song, Xue; Wen, Jing; Jiang, Ming; Zhu, Jun; Xu, Jianhua; Zhao, Lijun; Guo, Zhen; Wu, Jianfeng; He, Xia; Zhu, Xiangzhi.

Afiliação

Kong C; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Yu S; Department of Medical Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Qian P; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Song X; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Wen J; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Jiang M; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Zhu J; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Xu J; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Zhao L; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Guo Z; Department of Radiology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Wu J; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
He X; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Zhu X; Department of Radiation Oncology, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.

Front Oncol ; 13: 1169333, 2023.

Article em En | MEDLINE | ID: mdl-37771446

Palavras-chave

antiangiogenic TKIs; brain metastases; later-line; non-small cell lung cancer; whole-brain radiotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google